David will provide instrumental support at the crucial stage in formalising definitive agreements related to a number of
strategic commercial initiatives currently nearing execution with industry counterparts.
Clinical was 8 weeks from the start of April. Hopefully one of these initiatives is re the otc product, which indicates they are very confident it will be approved.
- Forums
- ASX - By Stock
- BOD
- Ann: Change in Chairman's role
Ann: Change in Chairman's role, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOD (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BOD (ASX) Chart |
Day chart unavailable